Literature DB >> 20789532

ANNOTATIONS.

.   

Abstract

Year:  1962        PMID: 20789532      PMCID: PMC1926347     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  11 in total

1.  Declining incidence of central nervous system anomalies in New York State.

Authors:  A M GITTELSOHN; S MILHAM
Journal:  Br J Prev Soc Med       Date:  1962-07

2.  M.R.L.41 in the treatment of secondary amenorrhoea and endometrial hyperplasia.

Authors:  D CHARLES
Journal:  Lancet       Date:  1962-08-11       Impact factor: 79.321

3.  Induction of ovulation with MRL/41. Preliminary report.

Authors:  R B GREENBLATT; W E BARFIELD; E C JUNGCK; A W RAY
Journal:  JAMA       Date:  1961-10-14       Impact factor: 56.272

4.  Gonadotrophin inhibiting and anti-fecundity effects of chloramiphene.

Authors:  D E HOLTKAMP; J G GRESLIN; C A ROOT; L J LERNER
Journal:  Proc Soc Exp Biol Med       Date:  1960-10

5.  Seasonal incidence of congenital disease in Birmingham.

Authors:  J H EDWARDS
Journal:  Ann Hum Genet       Date:  1961-05       Impact factor: 1.670

6.  Anencephaly and other congenital abnormalities. An epidemiological study in Northamptonshire.

Authors:  M J PLEYDELL
Journal:  Br Med J       Date:  1960-01-30

7.  The experimental approach to the problem of the congenital malformations.

Authors:  D H WOOLLAM
Journal:  Ann R Coll Surg Engl       Date:  1958-06       Impact factor: 1.891

8.  Epidemiology of stillbirths and infant deaths due to congenital malformation.

Authors:  W J ANDERSON; D BAIRD; A M THOMSON
Journal:  Lancet       Date:  1958-06-21       Impact factor: 79.321

9.  Seasonal incidence of congenital malformations of the central nervous system.

Authors:  T McKEOWN; R G RECORD
Journal:  Lancet       Date:  1951-01-27       Impact factor: 79.321

10.  Therapeutic abortions with a folic acid antagonist, 4-aminopteroylglutamic acid (4-amino P.G.A) administered by the oral route.

Authors:  J B THIERSCH
Journal:  Am J Obstet Gynecol       Date:  1952-06       Impact factor: 8.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.